Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-05

Clinical Trial Update: Porfimer Sodium in Diagnosing Patients With Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating porfimer sodium for diagnosing head and neck cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Porfimer Sodium (porfimer sodium)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED